News from decision resources A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jan 06, 2016, 08:30 ET
Decision Resources Group Logo.

Decision Resources Group Unifies Portfolio Under DRG Brand

 Decision Resources Group (DRG) announced that it has unified its portfolio of best-in-class companies under one brand. "The healthcare...

Dec 28, 2015, 08:30 ET
Decision Resources Group Logo

Several Therapies to Launch for Hemophilia A, Hemophilia B and Hemophilia with Inhibitors in the U.S. and E.U. through 2025

 Decision Resources Group forecasts that several therapies will launch for hemophilia A, hemophilia B and hemophilia with inhibitors in the...

Dec 22, 2015, 08:30 ET
Decision Resources Group Logo.

The Rising Prevalence of Diabetes and its Confounding Complications

 Decision Resources Group finds that the prevalent type 2 diabetes (T2D) population in the G7 (United States, France, Germany, Italy, Spain,...

Dec 21, 2015, 08:30 ET
Decision Resources Group Logo.

Novel Agents Are Set To Reverse The Decline In The Osteoporosis Market

 Decision Resources Group finds that, according to the Osteoporosis Pharmacor report, published December 2015, the osteoporosis market is...

Dec 18, 2015, 08:30 ET
Decision Resources Group Logo.

The Launches of Novel Routine Prophylactic Agents with Improved Administration Convenience Will Reshape the Hereditary Angioedema Market

 Decision Resources Group finds that the anticipated approvals of several prophylactic agents, including BioCryst's avoralstat and BCX-7353,...

Dec 17, 2015, 08:30 ET
Decision Resources Group Logo.

The Global Structural Heart Closure Device Market will Experience Strong Growth Through 2024, Driven Primarily by the Uptake of Endocardial LAA Closure for Stroke Prevention in Atrial Fibrillation Patients

 Decision Resources Group finds that the global structural heart closure device market will grow robustly over the next ten years, driven...

Dec 16, 2015, 10:00 ET
Decision Resources Group Logo.

PCSK9 Inhibitors Set to Achieve Blockbuster Status Despite Constraints on Use

 Decision Resources Group finds that the recently launched proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor class will be a key...

Dec 10, 2015, 08:30 ET
Decision Resources Group Logo.

The PD-1 inhibitors, Keytruda (pembrolizumab) and Opdivo (nivolumab), are prescribed by three-quarters of surveyed U.S. oncologists for previously treated, unresectable or metastatic malignant melanoma

Decision Resources Group finds that the majority of U.S. surveyed oncologists are aware of Merck & Co.'s Keytruda (pembrolizumab) and...

Dec 09, 2015, 08:30 ET
Decision Resources Group Logo.

The Prostate Cancer Drug Therapy Market Will More Than Double in Size Over the Next Decade and Reach $13.8 Billion in 2024 Across the United States, Europe and Japan

  Decision Resources Group finds that the prostate cancer drug therapy market will witness an impressive 9.6 percent annual growth over...

Dec 08, 2015, 08:30 ET
Decision Resources Group Logo.

European Physicians Report Strong but Variable Uptake of All-Oral Interferon-Free Hepatitis C Virus Regimens Across EU5 Countries

 Decision Resources Group finds that surveyed EU5 physicians report that more than half of their hepatitis C virus (HCV) patients were being...

Dec 07, 2015, 08:30 ET
Decision Resources Group Logo.

The Launch of Multiple First-in-Class Biologic Therapies will Transform the Chronic Pain Market Over the Next Decade

 Decision Resources Group finds that the launch of novel biologic therapies targeting nerve growth factor (NGF) or, to a lesser extent, the...

Nov 30, 2015, 08:30 ET
Decision Resources Group Logo.

The Malignant Melanoma Market Will Double to $3 Billion in 2024, Fueled by Uptake of Immune Checkpoint Inhibitors and Combination Therapies

 Decision Resources Group finds that immune checkpoint inhibitors, specifically CTLA-4 inhibitor Yervoy (Bristol-Myers Squibb/Ono...

Nov 24, 2015, 08:30 ET
Decision Resources Group Logo.

Despite the Budget Strains Affecting EU5 Healthcare Systems, Commercial Opportunity Awaits New Antibiotics Targeting Multi-Drug-Resistant Bacteria

 Decision Resources Group finds that variations in market access schemes across the EU5 countries (France, Germany, Italy, Spain and United...

Nov 19, 2015, 08:30 ET
Decision Resources Group Logo.

Novel Agents Contribute to Rapid Growth of Both the Type 2 Diabetes and Obesity Markets

 Decision Resources Group finds that, according to analyses of U.S. longitudinal patient-level claims data in the Treatment Algorithms: Type 2...

Nov 12, 2015, 08:30 ET
Nov 11, 2015, 08:30 ET
Decision Resources Group Logo.

A Large Prevalent Population and the Lack of an Approved Therapeutic Highlight Lucrative Market Opportunity in Nonalcoholic Steatohepatitis

 Decision Resources Group finds that the lack of a simple diagnostic test and low physician awareness coupled with the lack of therapeutics are...

Nov 09, 2015, 08:30 ET
Decision Resources Group Logo.

Increases in Vaccination Rates and Inclusion in Advisory Committee for Immunization Practices Recommendations Are Key Growth Drivers in the U.S. Adult Vaccine Market

 Decision Resources Group finds that 55 percent of surveyed physicians reported increased vaccination rates in the past twelve months across...

Nov 06, 2015, 08:30 ET
Decision Resources Group Logo.

The US Neurostimulation device market will experience strong growth through 2024, driven primarily by innovation-based expansion of the eligible patient population and growth in sales of replacement units

Decision Resources Group finds that the neurostimulation device market in the US will grow robustly over the next ten years, driven primarily by a...

Nov 05, 2015, 08:30 ET
Decision Resources Group Logo.

Clinical Trial Design Improvements Could Spur Drug Development for Autism and Traumatic Brain Injury, While Biomarkers Appear Key in the Discovery of Treatments for Amyotrophic Lateral Sclerosis

 Decision Resources Group finds that neurologists specializing in autism spectrum disorder (ASD) consider its heterogeneity a key obstacle to...

Nov 04, 2015, 08:30 ET
Decision Resources Group Logo.

Surveyed physicians report that acute kidney injury (AKI) is difficult to manage

Decision Resources Group finds that according to 44 percent of surveyed nephrologists and 37 percent of surveyed critical care physicians, AKI is...